Last updated on March 2019

A Study to Assess the Safety Tolerability and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis


Brief description of study

This is a study to evaluate the long-term safety and tolerability of bimekizumab in adult subjects with moderate to severe chronic plaque psoriasis (PSO).

Clinical Study Identifier: NCT03598790

Find a site near you

Start Over

Ps0014 940

Beverly, MA United States
  Connect »

Ps0014 929

Portland, OR United States
  Connect »

Ps0014 914

San Antonio, TX United States
  Connect »

Ps0014 622

Matsumoto, Japan
  Connect »

Ps0014 928

Fort Myers, FL United States
  Connect »

Ps0014 901

Newington, NH United States
  Connect »

Ps0014 947

Buffalo, NY United States
  Connect »

Ps0014 624

Obihiro, Japan
  Connect »

Ps0014 603

Sapporo, Japan
  Connect »

Ps0014 954

Skokie, IL United States
  Connect »

Ps0014 601

Fukuoka, Japan
  Connect »

Ps0014 618

Shinjuku-Ku, Japan
  Connect »

Ps0014 944

New Orleans, LA United States
  Connect »

Ps0014 671

Hamilton, Canada
  Connect »

Ps0014 675

Markham, Canada
  Connect »

Ps0014 663

Mississauga, Canada
  Connect »

Ps0014 607

Chiyoda-Ku, Japan
  Connect »

Ps0014 627

Itabashi-Ku, Japan
  Connect »

Ps0014 604

Minato-Ku, Japan
  Connect »

Ps0014 625

Nankoku, Japan
  Connect »

Ps0014 967

Santa Monica, CA United States
  Connect »

Ps0014 962

Owensboro, KY United States
  Connect »

Ps0014 657

Waterloo, Canada
  Connect »

Ps0014 250

Szolnok, Hungary
  Connect »